Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vicinitas Therapeutics is a biotech startup that specializes in developing medicines that impact patient lives.
CathWorks is a medical technology company focused transforming how cardiovascular disease is diagnosed and treated.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Apertura Gene Therapy is a biotechnology company that treats debilitating diseases with limited options.
Aurion Biotechnologies is a clinical-stage biotech company.
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
Stellar Health empowers providers and practice staff to deliver high-quality care through real-time notifications and meaningful incentives.
Jaguar Gene Therapy is accelerating breakthroughs in gene therapy for patients suffering from severe genetic diseases.
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
ConcertoCare is a provider of at-home and comprehensive care for seniors and other adults.
Appello Pharmaceuticals is a preclinical-stage company focused on CNS disorders.
CareMax is a technology-enabled care platform providing value-based care and chronic disease management to seniors.
DeepSight Technology's vision is to reinvent diagnostic imaging.
Novocardia treats cardiovascular care.
Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine.
Cureatr is a medication management and optimization company that sells tech and tech-enabled services to at-risk health care enterprises.
ARTMS is a developer of technology that transforms the production of diagnostic imaging isotopes.
Neomorph is a biotechnology company.
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
Springtide Child Development is a modern clinic to support children with developmental delays.
Bridge Medicines is a drug discovery company
Great Lakes Discoveries is a company set up by University of Michigan to boost drug commercialisation efforts.
Farapulse commercializing an innovative collection of catheter-based tools used to treat atrial fibrillation.
Deerfield has invested in 161 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Deerfield's top investment sectors include Health Care, Biotechnology, Medical, Life Science, Therapeutics. The firm invests across 20 different industry categories.
Among tracked funding rounds, Singular Genomics received $130.5M in a Convertible Note round. Deerfield's total known invested capital is $4.3B.
Deerfield's average investment size is $54.5M across its portfolio of 161 companies.
Recent Deerfield portfolio additions include Vicinitas Therapeutics, CathWorks, UTR Therapeutics Inc., Werewolf Therapeutics, Apertura Gene Therapy. These companies were founded in 2020 or later.